The Traderszone Network

Published in TZ Latest News 10 May, 2015 by The TZ Newswire Staff

Will Suitors Line Up to Buy These Biotech Stocks Next?

BioMarin Therapeutic Inc. and Amicus Therapeutics, Inc. are working on ultra-rare disease drugs that could attract an acquirer.